Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03160846Completed

The Inotrope Evaluation and Research Patient Registry

Role: lead

NCT01109810Completed

Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™)

Role: lead

NCT04035551Unknown

Health Evaluation And Learning for Total Parenteral Nutrition (TPN) at Home Patient Registry

Role: lead

NCT01974830Completed

AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry

Role: lead

All 4 trials loaded